| 95% CrI | Probability that Treatment Shows Small, Moderate or Large Improvement Relative to Placebo* | |||||
|---|---|---|---|---|---|---|
| Treatment (mg) | ES** | Low | High | Small | Moderate | Large |
| acetaminophen 4000 | -0.09 | -0.25 | 0.08 | 0.08 | 0.00 | 0 |
| nsNSAIDs | ||||||
| naproxen 1000 | -0.39 | -0.53 | -0.26 | >0.99 | 0.06 | 0.00 |
| ibuprofen 2400 | -0.41 | -0.63 | -0.18 | 0.96 | 0.20 | 0.00 |
| diclofenac 150 | -0.49 | -0.67 | -0.31 | >0.99 | 0.47 | 0.00 |
| COX-2 selective NSAIDs | ||||||
| celecoxib 100 | -0.11 | -0.31 | 0.10 | 0.18 | 0.00 | 0.00 |
| celecoxib 200 | -0.34 | -0.41 | -0.27 | >0.99 | 0.00 | 0.00 |
| celecoxib 400 | -0.27 | -0.45 | -0.10 | 0.81 | 0.01 | 0.00 |
| lumiracoxib 100 | -0.30 | -0.46 | -0.14 | 0.89 | 0.01 | 0.00 |
| lumiracoxib 200 | -0.27 | -0.44 | -0.10 | 0.80 | 0.00 | 0.00 |
| lumiracoxib 400 | -0.29 | -0.46 | -0.13 | 0.87 | 0.01 | 0.00 |
| etoricoxib 30 | -0.66 | -0.83 | -0.49 | >0.99 | 0.97 | 0.05 |
| etoricoxib 60 | -0.62 | -0.78 | -0.45 | >0.99 | 0.92 | 0.02 |